08:04 AM EDT, 08/21/2024 (MT Newswires) -- Redhill Biopharma ( RDHL ) said Wednesday it has launched Talicia by prescription in the United Arab Emirates to treat H. pylori infections in adults.

The company said the launch makes RedHill eligible for additional milestone payments, minimum sales payments, and tiered royalties up to the mid-teens percentage on net sales.

Talicia is a fixed-dose, all-in-one oral capsule combination of two antibiotics: amoxicillin and rifabutin, and a proton pump inhibitor, omeprazole, the company said. It was approved by the US Food and Drug Administration in 2019 for the treatment of H. pylori infection in adults.

Price: 8.74, Change: +0.21, Percent Change: +2.46